Pharmaceutical Raw Materials: How to Compare Active Substances, Excipients, and Auxiliary Substances Based on Key Properties

Photo: Julia Koblitz / Unsplash

Drug production requires precise selection of raw materials, where each category – active substances, excipients, and auxiliary substances – plays a specific role. While active substances determine the therapeutic effect, excipients ensure stability, solubility, or taste neutrality, and auxiliary substances optimize the manufacturing process. Comparing these groups based on key parameters such as purity, compatibility with other components, or sensitivity to moisture and temperature is crucial for maintaining quality and safety. Legislative requirements, particularly under REACH and pharmaceutical standards, also emphasize documentation and traceability of each raw material.

Active substances: How to assess efficacy and stability

Active pharmaceutical ingredients (APIs) are the core of every medicinal product, and their selection significantly influences the therapeutic effect. When comparing APIs, it is crucial to evaluate not only their efficacy but also their stability under various conditions. Efficacy is typically verified through standard pharmacological tests, which include in vitro studies (e.g., binding affinities to target receptors) and in vivo models (e.g., animal tests or clinical trials). API stability is assessed based on resistance to temperature, humidity, light, and oxidative processes. For example, some substances require storage at temperatures below 8 °C, while others remain stable even at room temperature. It is also important to consider interactions with excipients, which may affect the solubility or bioavailability of the API.

Another critical factor is the purity of the API, which is governed by pharmacopoeia requirements and regulations such as REACH or GMP. Purity is verified using chromatographic methods (e.g., HPLC) and spectroscopic techniques (e.g., NMR). Manufacturers must ensure that impurities do not exceed the specified limits, which vary depending on the type of substance and its therapeutic use. For example, highly potent APIs (HPAPIs) have stricter purity requirements than conventional drugs. When selecting an API supplier, it is therefore essential to verify that they meet all regulatory requirements and provide documentation confirming the quality and stability of the raw material.

Excipients: Functionality and Compatibility with APIs

Excipients, often referred to as inactive ingredients, play a key role in medicinal products, even though they themselves have no therapeutic effect. Their primary function is to ensure the stability, processability, and bioavailability of the API. When selecting excipients, it is necessary to assess their compatibility with the active ingredient, as an incorrect combination can lead to API degradation or reduced drug efficacy. For example, some excipients may catalyze hydrolytic or oxidative reactions, resulting in loss of stability. Therefore, compatibility studies are conducted prior to formulation, involving accelerated aging of samples under elevated temperature and humidity conditions.

Another important parameter is the functionality of excipients in a specific dosage form. For example, in tablets, fillers (e.g., lactose, microcrystalline cellulose), binders (e.g., hypromellose), and lubricants (e.g., magnesium stearate) are used to ensure mechanical strength and proper API release. In liquid preparations, solvents, emulsifiers, and stabilizers are key, as they influence solubility and homogeneity. When selecting excipients, their safety profile must also be considered, particularly for substances intended for parenteral or pediatric use, where toxicity requirements are stricter.

Photo: Hans Reniers / Unsplash

Excipients: How to choose the right additives for a specific application

Although often confused with excipients, excipients have specific roles in the technological process of drug production. They include, for example, colorants, preservatives, flavorings, or pH-adjusting agents. Their selection depends on the desired properties of the final product, such as taste, appearance, shelf life, or ease of application. For instance, preservatives (e.g., parabens, benzoic acid) are used to extend the shelf life of liquid preparations but must be compatible with the API and other ingredients. When selecting them, their effectiveness within the given pH range and potential interactions with packaging materials must be considered.

Another group of excipients includes substances that improve the solubility or permeability of APIs, such as surfactants (e.g., polysorbates) or cyclodextrins. These substances can significantly influence bioavailability, particularly for poorly soluble APIs. However, care must be taken to avoid undesirable side effects, such as mucosal irritation or allergic reactions. The selection of excipients should always be based on thorough testing of stability, safety, and efficacy in combination with the API and other excipients to ensure compliance with all regulatory requirements.

Regulatory and Technological Aspects of Raw Material Selection

The selection of pharmaceutical raw materials is not merely a technical matter but must also meet strict regulatory requirements. In the European Union, raw materials are governed by REACH regulations and GMP guidelines, which set requirements for quality, safety, and documentation. Each raw material must be accompanied by a detailed specification, including analytical methods for verifying identity, purity, and active substance content. Suppliers of raw materials should provide certificates of analysis (CoA) and documentation confirming compliance with pharmacopoeial monographs (e.g., the European Pharmacopoeia).

Technological aspects of raw material selection include assessing their processability in the manufacturing process. For example, in tablets, the flowability of powders, their compressibility, and the ability to form strong bonds are important. For liquid preparations, solubility and the stability of emulsions or suspensions are key. Manufacturers should conduct pilot tests with new raw materials to verify their behavior under real production conditions. It is also important to consider economic factors, such as the cost of raw materials and their availability, without compromising the quality of the final product. Proper raw material selection thus requires a combination of expertise, regulatory compliance, and technological experience.

Photo: Trnava University / Unsplash

Purity and Microbiological Quality: Criteria for Pharmaceutical Raw Materials

The purity of raw materials is a fundamental prerequisite for the production of safe and effective pharmaceuticals. For active pharmaceutical ingredients (APIs), pharmaceutical-grade quality is required, which includes not only high chemical purity (typically 98–100%) but also a low content of impurities such as residual solvents, heavy metals, or degradation products. These parameters are verified using standard analytical methods, such as chromatography or spectroscopy, and must comply with the limits specified in pharmacopoeial monographs (e.g., the European Pharmacopoeia). For excipients and auxiliary substances, purity is equally crucial, although the requirements may be less stringent—for example, fillers or binders may suffice with a purity of 95–99%, provided they do not affect the stability or bioavailability of the API.

Microbiological quality is another critical factor, particularly for raw materials intended for parenteral or ophthalmic preparations. According to Good Manufacturing Practice (GMP) requirements, raw materials must exhibit a low content of microorganisms, endotoxins, and mycotoxins. For oral and topical applications, the limits are less strict, but maximum permissible values for the total count of aerobic microorganisms and specific pathogens (e.g., Escherichia coli, Salmonella) must still be observed. Control is carried out using standard microbiological methods, such as cultivation or rapid tests based on PCR. Selecting a supplier with a certified quality management system (e.g., ISO 9001) minimizes the risk of contamination and ensures consistent raw material quality.

Physicochemical Properties and Their Impact on Processability

The physicochemical properties of raw materials directly influence their processability in pharmaceutical manufacturing. For active pharmaceutical ingredients, solubility is key, as it determines bioavailability—for example, poorly soluble APIs may require the use of solubilizing excipients or technological modifications (micronization, amorphization). Particle size is also important, as it affects the homogeneity of mixtures and dissolution rate. For solid dosage forms, APIs with a defined particle size distribution (e.g., 10–50 μm) are often used to ensure dosing consistency and the stability of tablets or capsules.

For excipients and auxiliary substances, properties such as bulk density, flowability, wettability, or gel-forming ability play a key role. For example, tablet fillers (lactose, microcrystalline cellulose) must have good compressibility and low hygroscopicity to prevent stickiness or degradation during storage. In liquid and semi-solid preparations (ointments, gels), rheological properties are crucial – viscosity and thixotropy determine the ease of application and the stability of emulsions or suspensions. Selecting raw materials with suitable physicochemical parameters enables the optimization of manufacturing processes, reduces modification costs, and minimizes the risk of production defects.

Stability and Compatibility of Raw Materials Under Various Storage Conditions

The stability of raw materials is essential for maintaining their functionality and safety throughout the entire shelf life of a medicinal product. Active substances must remain stable not only in their pure form but also in combination with excipients and auxiliary substances. Factors such as temperature, humidity, light, or oxygen can accelerate degradation – for example, hydrolytic reactions in esters or oxidation in unsaturated compounds. To assess stability, accelerated tests are conducted according to ICH guidelines (e.g., storage at 40 °C and 75 % relative humidity for 6 months), which simulate long-term conditions and allow for shelf-life prediction.

Compatibility of raw materials is just as important as their individual stability. Some excipients may interact with the API or other auxiliary substances, leading to changes in color, odor, efficacy, or even the formation of toxic products. For instance, acidic excipients (citric acid) can accelerate the degradation of basic APIs, while certain antioxidants (ascorbic acid) may react with metal ions and cause color changes. Therefore, before introducing a new raw material into a formulation, it is essential to conduct compatibility studies, which include analyzing raw material mixtures under various conditions (temperature, humidity, light). These studies help identify potential risks and optimize the composition of the medicinal product for maximum stability and safety.

Need raw materials with guaranteed quality?

Every pharmaceutical raw material from GCG Group is supplied with complete technical documentation and safety data sheets (SDS) that meet the requirements of current legislation. Our experts will advise you on selecting raw materials tailored to your production needs and specifications. Contact us – or browse our catalog of over 1,300 products right away.